BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37335962)

  • 1. Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial.
    Roder C; Stummer W; Coburger J; Scherer M; Haas P; von der Brelie C; Kamp MA; Löhr M; Hamisch CA; Skardelly M; Scholz T; Schipmann S; Rathert J; Brand CM; Pala A; Ernemann U; Stockhammer F; Gerlach R; Kremer P; Goldbrunner R; Ernestus RI; Sabel M; Rohde V; Tabatabai G; Martus P; Bisdas S; Ganslandt O; Unterberg A; Wirtz CR; Tatagiba M
    J Clin Oncol; 2023 Dec; 41(36):5512-5523. PubMed ID: 37335962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
    Coburger J; Hagel V; Wirtz CR; König R
    PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma.
    Quick-Weller J; Lescher S; Forster MT; Konczalla J; Seifert V; Senft C
    Br J Neurosurg; 2016 Jun; 30(3):313-7. PubMed ID: 26743016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
    Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
    Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
    Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
    Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.
    Müther M; Koch R; Weckesser M; Sporns P; Schwindt W; Stummer W
    Neurosurgery; 2019 Dec; 85(6):E1020-E1029. PubMed ID: 31215632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative imaging technology to maximise extent of resection for glioma.
    Jenkinson MD; Barone DG; Bryant A; Vale L; Bulbeck H; Lawrie TA; Hart MG; Watts C
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012788. PubMed ID: 29355914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological Insights on Imaging Results of Intraoperative Magnetic Resonance Imaging, 5-Aminolevulinic Acid, and Intraoperative Ultrasound in Glioblastoma Surgery.
    Coburger J; Scheuerle A; Pala A; Thal D; Wirtz CR; König R
    Neurosurgery; 2017 Jul; 81(1):165-174. PubMed ID: 28204539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Intra-operative MRI (iMRI) in Improving Extent of Resection and Survival in Patients with Glioblastoma Multiforme.
    Khan I; Waqas M; Shamim MS
    J Pak Med Assoc; 2017 Jul; 67(7):1121-1123. PubMed ID: 28770902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and
    Pala A; Reske SN; Eberhardt N; Scheuerle A; König R; Schmitz B; Beer AJ; Wirtz CR; Coburger J
    Neurosurg Rev; 2019 Jun; 42(2):471-479. PubMed ID: 29808321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial impact of high-field intraoperative magnetic resonance imaging on the efficacy of pediatric low-grade glioma surgery.
    Roder C; Breitkopf M; Ms ; Bisdas S; Freitas Rda S; Dimostheni A; Ebinger M; Wolff M; Tatagiba M; Schuhmann MU
    Neurosurg Focus; 2016 Mar; 40(3):E13. PubMed ID: 26926053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing maximum resection of glioblastoma: Raman spectroscopy versus 5-aminolevulinic acid.
    Herta J; Cho A; Roetzer-Pejrimovsky T; Höftberger R; Marik W; Kronreif G; Peilnsteiner T; Rössler K; Wolfsberger S
    J Neurosurg; 2023 Aug; 139(2):334-343. PubMed ID: 36681953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
    J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Intraoperative Magnetic Resonance Imaging and Intraoperative Fluorescence to Enhance the Resection of Contrast Enhancing Gliomas.
    Gessler F; Forster MT; Duetzmann S; Mittelbronn M; Hattingen E; Franz K; Seifert V; Senft C
    Neurosurgery; 2015 Jul; 77(1):16-22; discussion 22. PubMed ID: 25812066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
    Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J
    Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.
    Fukui A; Muragaki Y; Saito T; Maruyama T; Nitta M; Ikuta S; Kawamata T
    World Neurosurg; 2017 Feb; 98():73-80. PubMed ID: 27989974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-ALA dose on resection of glioblastoma.
    Michael AP; Watson VL; Ryan D; Delfino KR; Bekker SV; Cozzens JW
    J Neurooncol; 2019 Feb; 141(3):523-531. PubMed ID: 30644009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery.
    Della Pepa GM; Ius T; La Rocca G; Gaudino S; Isola M; Pignotti F; Rapisarda A; Mazzucchi E; Giordano C; Dragonetti V; Chiesa S; Balducci M; Gessi M; Skrap M; Olivi A; Marchese E; Sabatino G
    Neurosurgery; 2020 Jun; 86(6):E529-E540. PubMed ID: 32186345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Use Intraoperative MRI in Glioblastoma Surgery: Results of Resection, Histopathologic Assessment, and Surgical Site Infections.
    Wach J; Goetz C; Shareghi K; Scholz T; Heßelmann V; Mager AK; Gottschalk J; Vatter H; Kremer P
    J Neurol Surg A Cent Eur Neurosurg; 2019 Nov; 80(6):413-422. PubMed ID: 31272122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.